Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

por Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Publicado 2010

(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel

por Lewington, V., Lambert, B., Poetschger, U., Sever, Z. Bar, Giammarile, F., McEwan, A. J. B., Castellani, Rita, Lynch, T., Shulkin, B., Drobics, M., Staudenherz, A., Ladenstein, R.
Publicado 2016

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI

por Guo, J, Glass, J O, McCarville, M B, Shulkin, B L, Daryani, V M, Stewart, C F, Wu, J, Mao, S, Dwek, J R, Fayad, L M, Madewell, J E, Navid, F, Daw, N C, Reddick, W E
Publicado 2015